4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000016
Director sold 10,722 shares at $21.64 ($232,024)
- Director acquired 23,900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
FOUSE JACQUALYN A · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +23,900 | 139,975 | D | ||
| 2024-01-24 | Sale : show line 2 in the form 10b5-1 | −10,722 | $21.64 | $232,024 | 129,253 | D |
| Open-market sales · 10,722 sh · avg $21.64 · $232,024 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-20 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −23,900 | 0 | D |
Loading xslF345X05/wk-form4_1706131320.xml…